Surveillance of adverse drug events associated with etanercept prescribed for juvenile idiopathic arthritis in a single center up to 9-years: A retrospective observational study

The introduction of biologic agents opened a new era of treatment of juvenile idiopathic arthritis (JIA) over the past decade. From clinical experience, it appears that biological agents are well tolerated overall, and serious adverse events are rare. However, such clinical studies have not been con...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jeong Yun, Chung, Jee Eun, Park, Ji Hyun, Cho, Yoon Sook, Jung, Yong Woo, Choi, Soo An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226161/
https://www.ncbi.nlm.nih.gov/pubmed/30412634
http://dx.doi.org/10.1371/journal.pone.0204573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226161/
https://www.ncbi.nlm.nih.gov/pubmed/30412634
http://dx.doi.org/10.1371/journal.pone.0204573

Ejemplares similares